Publicaciones en las que colabora con Fernando Martínez García (45)

2023

  1. Persistence and determinants of blood pressure phenotypes according to office and ambulatory blood pressure measurements in youth

    Hypertension Research, Vol. 46, Núm. 5, pp. 1257-1266

2022

  1. DECREASED URINARY LEVELS OF SIRT1 AS NON-INVASIVE BIOMARKER OF EARLY RENAL DAMAGE IN HYPERTENSION

    Journal of hypertension, Vol. 40, pp. e249

  2. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

    The Lancet, Vol. 400, Núm. 10367, pp. 1927-1937

  3. IMPACT OF ATRIAL FIBRILLATION ON RENAL FUNCTION IN HEART FAILURE PATIENTS USING REAL WORLD DATA

    Journal of hypertension, Vol. 40, pp. e76

  4. Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

    ESC Heart Failure, Vol. 9, Núm. 6, pp. 4230-4239

  5. Insights From Matched Office and Ambulatory Blood Pressure in Youth: Clinical Relevance

    Hypertension (Dallas, Tex. : 1979), Vol. 79, Núm. 6, pp. 1237-1246

  6. PERSISTENCE OF BLOOD PRESSURE PHENOTYPES ACCORDING TO OFFICE AND 24 HOUR AMBULATORY BLOOD PRESSURE IN CHILDREN

    Journal of hypertension, Vol. 40, pp. e22

  7. REAL WORLD IMPACT OF BLOOD PRESSURE CHANGES ON MORBIDITY AND MORTALITY IN TYPE 2 DIABETES

    Journal of hypertension, Vol. 40, pp. e186

  8. Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Impact of obesity in kidney diseases

    Nutrients, Vol. 13, Núm. 12

  2. Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation

    Frontiers in Cardiovascular Medicine, Vol. 8

  3. Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension

    Hypertension (Dallas, Tex. : 1979), Vol. 77, Núm. 3, pp. 960-971

2020

  1. Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease

    Journal of hypertension, Vol. 38, Núm. 10, pp. 2036-2042

2019

  1. Immune-unreactive urinary albumin as a predictor of cardiovascular events: The Hortega Study

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 4, pp. 633-641

2018

  1. Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension

    Journal of Translational Medicine, Vol. 16, Núm. 1

  2. Urinary podocyte-associated molecules and albuminuria in hypertension

    Journal of Hypertension, Vol. 36, Núm. 8, pp. 1712-1718

2017

  1. Multimorbidity and acute heart failure in internal medicine

    International Journal of Cardiology, Vol. 232, pp. 208-215

2016

  1. Genomic and metabolomic profile associated to clustering of cardio-metabolic risk factors

    PLoS ONE, Vol. 11, Núm. 9

  2. Pulse pressure amplification and its determinants

    Blood Pressure, Vol. 25, Núm. 1, pp. 21-27

2015

  1. Carotid-femoral pulse wave velocity assessment by two differentmethods: Implications for risk assessment

    Journal of Hypertension, Vol. 33, Núm. 9, pp. 1868-1875